NCT03476239 Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE3
NCT03469661 Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS) Status COMPLETED Phase N/A
NCT03465540 Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies Status TERMINATED Phase PHASE1
NCT03461211 Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study Status COMPLETED Phase PHASE3
NCT03456856 A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction. Status COMPLETED Phase PHASE4
NCT03451422 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT03448731 Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA) Status COMPLETED Phase PHASE2
NCT03442569 PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC Status COMPLETED Phase PHASE2
NCT03433755 Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia Status TERMINATED Phase PHASE3
NCT03432533 A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis Status COMPLETED Phase PHASE3
NCT03430687 Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma Status WITHDRAWN Phase PHASE1
NCT03422627 Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease Status TERMINATED Phase PHASE1/PHASE2
NCT03410056 Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis Status TERMINATED Phase PHASE1/PHASE2
NCT03406078 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma Status COMPLETED Phase PHASE3
NCT03403374 Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE4
NCT03398954 a Prospective Pilot Study of Screening Out Rate and Clinical Management of Familial Hypercholesterolemia Status UNKNOWN Phase N/A